CymaBay Therapeutics, Inc.

ProShare Advisors LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

25,976

Value ($000)

614

Weight

0.0%

2019 Q4 - 2023 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	614	0.0%	25,976	12/31/2023
2023 Q3	11/13/2023	286	0.0%	19,159	9/30/2023
2023 Q2	8/10/2023	209	0.0%	19,066	6/30/2023
2022 Q1	5/10/2022	76	0.0%	24,721	3/31/2022
2021 Q4	2/8/2022	92	0.0%	27,065	12/31/2021
2021 Q3	11/12/2021	86	0.0%	23,622	9/30/2021
2021 Q2	8/13/2021	132	0.0%	30,378	6/30/2021
2021 Q1	5/14/2021	127	0.0%	28,039	3/31/2021
2020 Q4	2/9/2021	149	0.0%	25,981	12/31/2020
2020 Q3	11/13/2020	142	0.0%	19,592	9/30/2020
2020 Q2	8/3/2020	71	0.0%	20,419	6/30/2020
2020 Q1	5/15/2020	20	0.0%	13,485	3/31/2020
2019 Q4	2/12/2020	47	0.0%	24,195	12/31/2019